Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.41 |
| ▸ | FABP4 | P15090 | 1/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.41 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.35 |
| ▸ | SLC9A2 | Q9UBY0 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1005423 | 0.98 | FABP3 (0.40) | FABP3FABP4FABP5SLC9A1SLC9A2 | |
| Ammonia Solution, Strong SCHEMBL11578768 | 0.98 | FABP3 (0.40) | FABP3FABP4FABP5SLC9A1SLC9A2 | |
| SCHEMBL2553027 | 0.82 | GABRA1 (0.43) | FABP3FABP4FABP5L3MBTL1LMNA | |
| Imidazole SCHEMBL1006649 | 0.82 | ALDH1A1 (0.35) | FABP3FABP4FABP5ALDH1A1 | |
| Tetrazole SCHEMBL2254943 | 0.82 | FABP3 (0.30) | FABP3FABP4FABP5 | |
| SCHEMBL971368 | 0.82 | L3MBTL1 (0.32) | FABP3FABP4FABP5SLC9A1SLC9A2 | |
| Ammonia Solution, Strong SCHEMBL23749140 | 0.81 | GABRA1 (0.42) | FABP3FABP4FABP5L3MBTL1LMNA | |
| SCHEMBL216708 | 0.80 | TRPV4 (0.38) | SLC9A1SLC9A2L3MBTL1HPGDALDH1A1 | |
| SCHEMBL10980384 | 0.80 | L3MBTL1 (0.32) | SLC9A1SLC9A2L3MBTL1HPGDALDH1A1 | |
| SCHEMBL30010765 | 0.80 | TRPV4 (0.38) | SLC9A1SLC9A2L3MBTL1HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1163550-B1 | HYDROXY-AMINO THERMALLY CURED UNDERCOAT FOR 193 NM LITHOGRAPHY | FUJIFILM ELECTRONIC MATERIALS (US) | 2007-05-30 | — | — | EP | claimed |
| US-7026478-B2 | Iron catalyzed cross coupling reactions of aromatic compounds | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2006-04-11 | — | — | US | claimed |
| US-20030220498-A1 | Iron catalyzed cross coupling reactions of aromatic compounds | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2003-11-27 | — | — | US | claimed |
| US-5473104-A | Reacting sulfonated 3-hydroxybutyrolactone with trimethylamine , decyclization | NEUROCRINE BIOSCIENCES, INC. (US) | 1995-12-05 | — | — | US | claimed |
| US-5276149-A | Antibiotics | MERCK & CO., INC. (US) | 1994-01-04 | — | — | US | claimed |
| EP-4346815-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | Schrödinger, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4288436-A1 | TRICYCLIC COMPOUNDS AND USES THEREOF | HUTCHMED Limited (CN) | 2023-12-13 | — | — | EP | disclosed |
| CN-113677293-B | Curable composition for dental restoration | 可乐丽则武齿科株式会社 | 2023-10-10 | — | — | CN | disclosed |
| WO-2022262691-A1 | HETEROCYCLIC COMPOUNDS AS SOS1 INHIBITORS | BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022171018-A1 | SUBSTITUTED BENZOPYRIMIDINE OR PYRIDOPYRIMIDINE AMINE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州泽璟生物制药股份有限公司 | 2022-08-18 | — | — | WO | disclosed |
| WO-2022083657-A1 | SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 苏州泽璟生物制药股份有限公司 | 2022-04-28 | — | — | WO | disclosed |
| CN-102844114-B | For preparing the metal catalyst composition of furfural derivatives from lignocellulosic biomass raw material and utilizing the preparation method of furfural derivatives of this metal catalyst composition | 韩国生产技术研究院 | 2016-06-08 | — | — | CN | disclosed |
| WO-1984001779-A1 | PROCESS FOR THE PRODUCTION OF OLIGONUCLEOTIDES | KOESTER HUBERT (DE) | 1984-05-10 | — | — | WO | disclosed |
| EP-0102995-A1 | POLYNUCLEOTIDE SYNTHESIS | CELLTECH LIMITED (GB) | 1984-03-21 | — | — | EP | disclosed |
| US-4409209-A | POTENTIATION OF ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1983-10-11 | — | — | US | disclosed |
| WO-1983003098-A1 | POLYNUCLEOTIDE SYNTHESIS | EATON, MICHAEL, ANTHONY, WILLIAM | 1983-09-15 | — | — | WO | disclosed |
| US-4323560-A | IMMUNOPOTENTIATING ACTION TO INCREASE ANTIBIOTIC EFFECTIVENESS | CIBA-GEIGY CORPORATION (US) | 1982-04-06 | — | — | US | disclosed |
| EP-0027258-A1 | Phosphoryl muramyl peptides, method for their preparation and their use in medicines | CIBA-GEIGY AG (CH) | 1981-04-22 | — | — | EP | disclosed |
| US-4194952-A | BY EVAPORATION OF WATER WITH ADDITION OF ANTIFORAM AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-03-25 | — | — | US | disclosed |
| US-4056673-A | VIRICIDE, ANTINEOPLASTIC | HOFFMANN-LA ROCHE INC. (US) | 1977-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220498-A1 | Iron catalyzed cross coupling reactions of aromatic compounds | ARRB1, RBX1, CYP4X1 | FABP3 3840/4885FABP4 3224/4885FABP5 4412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.